| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |